[HTML][HTML] Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD
…, E St. Rose, S Ballal, J McLaren… - … England Journal of …, 2020 - Mass Medical Soc
Background Triple fixed-dose regimens of an inhaled glucocorticoid, a long-acting
muscarinic antagonist (LAMA), and a long-acting β 2 -agonist (LABA) for chronic obstructive …
muscarinic antagonist (LAMA), and a long-acting β 2 -agonist (LABA) for chronic obstructive …
[HTML][HTML] A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co …
…, R Trivedi, E St Rose, S Ballal, J McLaren… - Respiratory …, 2019 - Elsevier
Background Single inhaler triple therapies providing an inhaled corticosteroid, a long-acting
muscarinic antagonist, and a long-acting β 2 -agonist (ICS/LAMA/LABAs) are an emerging …
muscarinic antagonist, and a long-acting β 2 -agonist (ICS/LAMA/LABAs) are an emerging …
[HTML][HTML] Management of patients with Graves' orbitopathy: initial assessment, management outside specialised centres and referral pathways
…, J Hickey, JH Lazarus, CJ MacEwen, J McLaren… - Clinical …, 2015 - ncbi.nlm.nih.gov
Graves’ orbitopathy (GO) is uncommon, but responsible for considerable morbidity. A
coordinated approach between healthcare professionals is required in order to meet the needs of …
coordinated approach between healthcare professionals is required in order to meet the needs of …
Multiple forces in component localisation in China
M Eberhardt, J McLaren, A Millington… - European Management …, 2004 - Elsevier
Successful localisation of component sourcing is of key concern to the manufacturing
subsidiaries of MNCs. However, a range of factors both internal and external to the firm can act as …
subsidiaries of MNCs. However, a range of factors both internal and external to the firm can act as …
[PDF][PDF] Policy capacities for transformative innovation policy: A case study of UK Research and Innovation
J McLaren, R Kattel - UCL Institute for Innovation and Public Purpose …, 2022 - ucl.ac.uk
The 2008 financial collapse, climate crisis and COVID-19 have raised many questions about
the sustainability of current systems and how to rebalance the impacts these have on, for …
the sustainability of current systems and how to rebalance the impacts these have on, for …
Human resource barriers to partnership sourcing in China
B Wilkinson, M Eberhardt, J McLaren… - … International Journal of …, 2005 - Taylor & Francis
Building on previous research on both buyer–supplier relations and human resource
management in the PRC, interviews with managers in each of 47 UK-owned PRC subsidiaries …
management in the PRC, interviews with managers in each of 47 UK-owned PRC subsidiaries …
[HTML][HTML] Efficacy and safety of budesonide/formoterol pMDI vs budesonide pMDI in asthmatic children (6–< 12 years)
DS Pearlman, G Eckerwall, J McLaren… - Annals of Allergy …, 2017 - Elsevier
Background The efficacy and safety of budesonide/formoterol pressurized metered-dose
inhaler (pMDI) have been demonstrated in patients with asthma at least 12 years old. Objective …
inhaler (pMDI) have been demonstrated in patients with asthma at least 12 years old. Objective …
Diagnosis of Graves' orbitopathy (DiaGO): results of a pilot study to assess the utility of an office tool for practicing endocrinologists
Context: In active Graves’ orbitopathy (GO), treatment can improve the final cosmetic and
visual outcome. Diagnostic delay results in significant morbidity and increases patient …
visual outcome. Diagnostic delay results in significant morbidity and increases patient …
Learning analytics suggest a positive experience
J McLaren, J Donaldson, S Smith - 17th European Conference on e …, 2018 - storre.stir.ac.uk
Massive Open Online Courses (MOOCs) are a relatively new phenomenon not just in
healthcare but also in education as a whole (Sarabia-Cobo et al, 2015; Parkinson, 2015). Their …
healthcare but also in education as a whole (Sarabia-Cobo et al, 2015; Parkinson, 2015). Their …
Seasonal variation in COPD exacerbation rates: budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) at two ICS dose levels in the ETHOS trial
…, R Trivedi, E Rose, S Ballal, J Mclaren… - …, 2021 - thieme-connect.com
Background: In the Phase III, 52-week ETHOS study (NCT02465567), BGF MDI triple fixed-dose
combination, reduced moderate/severe COPD exacerbation rate vs. dual therapies; …
combination, reduced moderate/severe COPD exacerbation rate vs. dual therapies; …